<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04622410</url>
  </required_header>
  <id_info>
    <org_study_id>S51836</org_study_id>
    <nct_id>NCT04622410</nct_id>
  </id_info>
  <brief_title>Registry for Hirschsprung Disease of the BELAPS</brief_title>
  <official_title>Registry for Hirschsprung Disease of the BELAPS (Belgian Association of Pediatric Surgery)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Registry for Hirschsprung disease of the BELAPS (Belgian Association of Pediatric Surgery)&#xD;
      Protocol Short Title/Acronym&#xD;
&#xD;
      / Sponsor name BELAPS Principal Investigator Prof. Dr. Marc Miserez Medical condition or&#xD;
      disease under investigation Hirschsprung's disease Purpose of clinical study To register&#xD;
      pre-, intra- and postoperative data in order to improve surgical care to paediatric patients&#xD;
      with Hirschsprung's disease in Belgium. Primary objective The primary objective is to&#xD;
      evaluate defecation habits at 3.5-5.5 years after surgery. Secondary objective (s) Evaluating&#xD;
      the long-term results and evaluate risk factors for constipation / incontinence. Study Design&#xD;
      Prospective registry Endpoints Krickenbeck score, urinary, sexual and QoL evaluation&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2012</start_date>
  <completion_date type="Anticipated">December 31, 2030</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2030</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>To register pre-, intra- and postoperative data in order to improve surgical care to pediatric patients with Hirschsprung's disease in Belgium.</measure>
    <time_frame>at least 10 years postoperatively</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">432</enrollment>
  <condition>Hirschsprung Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        -  All Hirschsprung disease patients consecutively&#xD;
&#xD;
          -  Male and female&#xD;
&#xD;
          -  &lt; 18 years&#xD;
&#xD;
          -  Operated by a participating surgeon&#xD;
&#xD;
          -  Elective and emergency surgery&#xD;
&#xD;
          -  Informed consent form signed by the parents of the child&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Hirschsprung Disease, surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Colette Barle</last_name>
    <email>colette.barle@uzleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colette Barl√©</last_name>
      <phone>++32 16 341699</phone>
      <email>colette.barle@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Marc Miserez, Prof.Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 5, 2020</study_first_submitted>
  <study_first_submitted_qc>November 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2020</study_first_posted>
  <last_update_submitted>November 5, 2020</last_update_submitted>
  <last_update_submitted_qc>November 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hirschsprung Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

